Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 28,962 | 55,633 | 42,332 | 27,687 | 52,203 |
Marketable Securities | 20,060 | 18,473 | 113,810 | 36,605 | 73,761 |
Receivables | 51,425 | 42,780 | 23,033 | 31,609 | 29,028 |
Inventories | 76,453 | 61,781 | 46,481 | 47,106 | 41,487 |
Income taxes - deferred | N/A | N/A | 6 | N/A | N/A |
Other current assets | 7,304 | 2,156 | 3,644 | 1,440 | 2,379 |
TOTAL | $191,592 | $186,383 | $235,791 | $147,268 | $200,846 |
Non-Current Assets | |||||
PPE Net | 19,761 | 71,153 | 57,684 | 780 | 884 |
Investments And Advances | 7,108 | 4,539 | 2,063 | 19,622 | 22,762 |
Intangibles | 78,350 | 93,730 | 14,364 | 4,277 | 5,426 |
Other Non-Current Assets | 52,921 | 24,153 | 306 | 368 | 590 |
TOTAL | $158,140 | $193,575 | $74,417 | $25,047 | $29,662 |
Total Assets | $349,732 | $379,958 | $310,208 | $172,315 | $230,508 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 0 | 508 | 10,333 | 0 | 8,182 |
Accounts payable and accrued liabilities | 43,703 | 32,710 | 24,937 | 21,813 | 35,403 |
Accrued Expenses | 23,288 | 30,030 | 21,744 | 11,615 | 11,387 |
Other current liabilities | 16,664 | 8,079 | 3,129 | 7,026 | 4,303 |
TOTAL | $83,655 | $85,551 | $63,524 | $40,454 | $84,142 |
Non-Current Liabilities | |||||
Long Term Debt | 1,623 | 1,945 | 0 | 0 | 4,091 |
Deferred Revenues | 0 | 8,725 | 3,381 | 0 | N/A |
Other Non-Current Liabilities | 1,340 | 2,954 | 2,323 | 6 | 606 |
TOTAL | $14,984 | $20,605 | $10,658 | $6 | $4,697 |
Total Liabilities | $98,639 | $106,156 | $74,182 | $40,460 | $88,839 |
Shareholders' Equity | |||||
Shares Outstanding, K | 32,838 | 32,080 | 31,840 | 28,137 | 27,921 |
Common Shares | 328 | 320 | 318 | 281 | 279 |
Retained earnings | -98,988 | -77,106 | -114,057 | -143,651 | -126,834 |
Other shareholders' equity | -17,482 | -3,374 | 487 | 2,500 | 2,162 |
TOTAL | $251,093 | $273,802 | $236,026 | $131,855 | $141,669 |
Total Liabilities And Equity | $349,732 | $379,958 | $310,208 | $172,315 | $230,508 |